LYN inhibition increases cancer cell apoptosis, and reduces cancer cell proliferation, migration, and invasion, likely by inactivating the WNT/Beta-Catenin and AKT/mTOR pathways and activating the mitochondrial apoptotic pathway [135]. The gene discussed is AKT1; the disease is cancer.